指南与共识介入神经骨肌USCT

成人慢性疼痛介入治疗中皮质类固醇的使用:交感神经与周围神经阻滞、扳机点注射——来自美国区域麻醉与疼痛医学学会、美国疼痛医学学会、美国介入疼痛医师学会和国际疼痛与脊柱介入学会的指南

Use of corticosteroids for adult chronic pain interventions: sympathetic and peripheral nerve blocks, trigger point injections - guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society.
指南 / 共识 · Reg Anesth Pain Med · 2026-06-05

该指南由美国区域麻醉与疼痛医学学会等四家学会制定,采用改良Delphi流程和USPSTF证据分级,针对成人慢性疼痛的交感神经阻滞、周围神经阻滞和扳机点注射中皮质类固醇的使用与安全性给出推荐。指南指出影像引导可提高部分操作安全性,非颗粒型皮质类固醇加入局麻药对丛集性头痛有益但对其他类型头痛无益,在腹横肌平面阻滞和腹股沟/髂腹下神经阻滞用于疝修补术后疼痛时可能提供额外获益但阴部神经阻滞无证据,扳机点注射中皮质类固醇获益极小。

要点

  • 影像引导可提高星状神经节阻滞、下肢周围神经阻滞及部分扳机点注射部位的安全性。
  • 非颗粒型皮质类固醇加入局麻药对丛集性头痛有益,但对其他类型头痛无益。
  • 皮质类固醇在腹横肌平面阻滞和腹股沟/髂腹下神经阻滞用于疝修补术后疼痛时可能提供额外获益。

核心结论

  • 指南就交感神经阻滞、周围神经阻滞和扳机点注射中皮质类固醇的使用给出推荐,以帮助临床医生做出知情决策。

研究设计与样本

  • 实践指南由美国区域麻醉与疼痛医学学会董事会批准,其他学会同意参与;专家进行全面文献综述并起草声明和推荐,采用改良Delphi流程经四轮讨论达成共识(≥75%同意),证据分级与推荐强度遵循美国预防服务工作组标准。

诊断标准与关键数值

  • 影像引导可提高星状神经节阻滞、下肢周围神经阻滞及部分扳机点注射部位的安全性。
  • 非颗粒型皮质类固醇加入局麻药对丛集性头痛有益,但对其他类型头痛无益。
  • 皮质类固醇在腹横肌平面阻滞和腹股沟/髂腹下神经阻滞用于疝修补术后疼痛时可能提供额外获益,但阴部神经阻滞无证据。
  • 扳机点注射中皮质类固醇的获益极小。

临床应用与阅片要点

  • 指南推荐在星状神经节阻滞、下肢周围神经阻滞及部分扳机点注射部位使用影像引导以提高安全性。
  • 指南指出非颗粒型皮质类固醇加入局麻药可用于丛集性头痛,但不推荐用于其他类型头痛。
  • 指南指出皮质类固醇可考虑用于腹横肌平面阻滞和腹股沟/髂腹下神经阻滞治疗疝修补术后疼痛,但阴部神经阻滞无证据。
  • 指南指出扳机点注射中皮质类固醇的获益极小。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: There is potential for adverse events from corticosteroid injections, including increase in blood glucose, decrease in bone mineral density and suppression of the hypothalamic-pituitary axis. Published studies note that doses lower than those commonly injected provide similar benefit.

METHODS: Development of the practice guideline was approved by the Board of Directors of American Society of Regional Anesthesia and Pain Medicine with several other societies agreeing to participate. The scope of guidelines was agreed on to include safety of the injection technique (landmark-guided, ultrasound or radiology-aided injections); effect of the addition of the corticosteroid on the efficacy of the injectate (local anesthetic or saline); and adverse events related to the injection. Based on preliminary discussions, it was decided to structure the topics into three separate guidelines as follows: (1) sympathetic, peripheral nerve blocks and trigger point injections; (2) joints; and (3) neuraxial, facet, sacroiliac joints and related topics (vaccine and anticoagulants). Experts were assigned topics to perform a comprehensive review of the literature and to draft statements and recommendations, which were refined and voted for consensus (≥75% agreement) using a modified Delphi process. The United States Preventive Services Task Force grading of evidence and strength of recommendation was followed.

RESULTS: This guideline deals with the use and safety of corticosteroid injections for sympathetic, peripheral nerve blocks and trigger point injections for adult chronic pain conditions. All the statements and recommendations were approved by all participants after four rounds of discussion. The Practice Guidelines Committees and Board of Directors of the participating societies also approved all the statements and recommendations. The safety of some procedures, including stellate blocks, lower extremity peripheral nerve blocks and some sites of trigger point injections, is improved by imaging guidance. The addition of non-particulate corticosteroid to the local anesthetic is beneficial in cluster headaches but not in other types of headaches. Corticosteroid may provide additional benefit in transverse abdominal plane blocks and ilioinguinal/iliohypogastric nerve blocks in postherniorrhaphy pain but there is no evidence for pudendal nerve blocks. There is minimal benefit for the use of corticosteroids in trigger point injections.

CONCLUSIONS: In this practice guideline, we provided recommendations on the use of corticosteroids in sympathetic blocks, peripheral nerve blocks, and trigger point injections to assist clinicians in making informed decisions.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Benzon HT, Elmofty D, Shankar H, et al. Use of corticosteroids for adult chronic pain interventions: sympathetic and peripheral nerve blocks, trigger point injections - guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society. Reg Anesth Pain Med. 2026. PMID: 39019502. doi:10.1136/rapm-2024-105593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。